Polar Capital Holdings PLC Vera Therapeutics, Inc. Transaction History
Polar Capital Holdings PLC
- $16 Billion
- Q1 2024
A detailed history of Polar Capital Holdings PLC transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, Polar Capital Holdings PLC holds 675,000 shares of VERA stock, worth $25.6 Million. This represents 0.18% of its overall portfolio holdings.
Number of Shares
675,000
Previous 725,000
6.9%
Holding current value
$25.6 Million
Previous $11.2 Million
161.04%
% of portfolio
0.18%
Previous 0.08%
Shares
2 transactions
Others Institutions Holding VERA
# of Institutions
173Shares Held
52.7MCall Options Held
117KPut Options Held
290K-
Avoro Capital Advisors LLC New York, NY5.27MShares$200 Million2.74% of portfolio
-
Black Rock Inc. New York, NY3.32MShares$126 Million0.0% of portfolio
-
Commodore Capital LP New York, NY3.17MShares$120 Million11.79% of portfolio
-
Abingworth LLP London, X02.96MShares$112 Million19.0% of portfolio
-
Sofinnova Investments, Inc. Menlo Park, CA2.79MShares$106 Million7.01% of portfolio
About Vera Therapeutics, Inc.
- Ticker VERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,042,300
- Market Cap $1.03B
- Description
- Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...